Literature DB >> 18558289

Comparative genomic hybridization identifies 17q11.2 approximately q12 duplication as an early event in cutaneous T-cell lymphomas.

Gianluca Barba1, Caterina Matteucci, Giampiero Girolomoni, Lucia Brandimarte, Emanuela Varasano, Massimo Fabrizio Martelli, Cristina Mecucci.   

Abstract

Mycosis fungoides (MF) and Sézary syndrome (SS) are primary cutaneous T-cell lymphomas (CTCL), a heterogeneous group of extranodal non-Hodgkin lymphomas. In the three cases of MF and four of SS studied, comparative genomic hybridization detected chromosomal imbalances in all SS cases and in one MF case. In all five abnormal cases, the long arm of chromosome 17 was completely or partially duplicated; in three of these five cases, it was the sole genomic event. Notably, a minimal common duplicated region at 17q11.2 approximately q12, corresponded to the mapping of HER2/neu and STAT family genes. The only recurrent loss involved chromosome 10, with deletion of the entire long arm in one case and deletion of band 10q23 in another. Sporadic imbalances included gains at chromosome arms 1q, 2q, 7p, 7q, and 12p. Genomic duplication at 17q11.2 approximately q12 emerged as a primary karyotypic abnormality common to both MF and SS, which suggests that this is an early clonal event.

Entities:  

Mesh:

Year:  2008        PMID: 18558289     DOI: 10.1016/j.cancergencyto.2008.03.007

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  8 in total

Review 1.  The biomarker landscape in mycosis fungoides and Sézary syndrome.

Authors:  Brittany Dulmage; Larisa Geskin; Joan Guitart; Oleg E Akilov
Journal:  Exp Dermatol       Date:  2017-02-02       Impact factor: 3.960

2.  Ectopic expression of embryonic stem cell and other developmental genes in cutaneous T-cell lymphoma.

Authors:  Ivan V Litvinov; Elena Netchiporouk; Brendan Cordeiro; Hanieh Zargham; Kevin Pehr; Martin Gilbert; Youwen Zhou; Linda Moreau; Anders Woetmann; Niels Ødum; Thomas S Kupper; Denis Sasseville
Journal:  Oncoimmunology       Date:  2014-12-21       Impact factor: 8.110

Review 3.  Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.

Authors:  Ryan A Wilcox
Journal:  Am J Hematol       Date:  2015-11-26       Impact factor: 10.047

Review 4.  Advances in the understanding and management of T-cell prolymphocytic leukemia.

Authors:  Kamel Laribi; Pierre Lemaire; Jeremy Sandrini; Alix Baugier de Materre
Journal:  Oncotarget       Date:  2017-11-01

5.  Analysis of CTCL cell lines reveals important differences between mycosis fungoides/Sézary syndrome vs. HTLV-1+ leukemic cell lines.

Authors:  Elena Netchiporouk; Jennifer Gantchev; Matthew Tsang; Philippe Thibault; Andrew K Watters; John-Douglas Matthew Hughes; Feras M Ghazawi; Anders Woetmann; Niels Ødum; Denis Sasseville; Ivan V Litvinov
Journal:  Oncotarget       Date:  2017-10-07

6.  T-cell prolymphocytic leukemia presenting with erythematous patches, plaques, and erythema gyratum-like lesions masquerading as Sézary syndrome.

Authors:  Leah Cohen; Adel Haque; Sophia Ma; Ling Zhang; Lubomir Sokol; Lucia Seminario-Vidal
Journal:  JAAD Case Rep       Date:  2019-08-05

Review 7.  Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma.

Authors:  Raman Preet Kaur Gill; Jennifer Gantchev; Amelia Martínez Villarreal; Brandon Ramchatesingh; Elena Netchiporouk; Oleg E Akilov; Niels Ødum; Robert Gniadecki; Sergei B Koralov; Ivan V Litvinov
Journal:  Cells       Date:  2022-02-09       Impact factor: 6.600

8.  TruSeq-Based Gene Expression Analysis of Formalin-Fixed Paraffin-Embedded (FFPE) Cutaneous T-Cell Lymphoma Samples: Subgroup Analysis Results and Elucidation of Biases from FFPE Sample Processing on the TruSeq Platform.

Authors:  Philippe Lefrançois; Michael T Tetzlaff; Linda Moreau; Andrew K Watters; Elena Netchiporouk; Nathalie Provost; Martin Gilbert; Xiao Ni; Denis Sasseville; Madeleine Duvic; Ivan V Litvinov
Journal:  Front Med (Lausanne)       Date:  2017-09-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.